NCT07128316 is a NA clinical trial of Contoura Topolyzer with Phorcides in Myopia, sponsored by 59th Medical Wing.

Who is sponsoring NCT07128316?

NCT07128316 is sponsored by 59th Medical Wing.

What drugs are being tested in NCT07128316?

Interventions in NCT07128316: Contoura Topolyzer with Phorcides, iDesign.

What condition does NCT07128316 study?

NCT07128316 studies Myopia, Astigmatism.

Is NCT07128316 still recruiting?

NCT07128316 is currently active, enrolled. Last updated 18 August 2025.

Last reviewed 2025-08-18 · How we verify

NCT07128316

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

LASIK Using Contoura With Phorcides vs. iDesign

Active, enrolled NA Last updated 18 August 2025

What this trial tests

NA trial testing Contoura Topolyzer with Phorcides in Myopia in 63 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

11 September 2023

Primary endpoint
15 December 2025

15 December 2025

Quick facts

Lead sponsor	59th Medical Wing
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	63
Start date	11 September 2023
Primary completion	15 December 2025
Estimated completion	15 December 2025
Sites	1 location across United States

Drugs / interventions tested

Contoura Topolyzer with Phorcides
iDesign

Conditions studied

Myopia — all drugs for Myopia →
Astigmatism — all drugs for Astigmatism →

Sponsor

59th Medical Wing — full company profile →

Who can join

Adults 21 to 50, any sex, with Myopia or Astigmatism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Participants will undergo LASIK using Contoura with Phorcides calculation on one eye and LASIK using iDesign calculation on the contralateral eye to correct myopia.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Myopia

Currently open trials in the same condition.

NCT07284966 — Comfort and Vision With TOTAL30 Multifocal Lenses · recruiting
NCT07078799 — Wavefront-guided LASIK Surgery Compared to Ray Tracing-Guided LASIK Surgery · NA · recruiting
NCT07585877 — Effect of Branched-Chain Amino Acid Supplementation on Myopia Progression · NA · active not recruiting
NCT07354945 — An Evaluation of Myopia Control Lenses on Wearing Experience in Myopic Children · NA · recruiting
NCT07229365 — Children's Viewing Behavior · NA · recruiting

Other 59th Medical Wing trials

Trials by the same sponsor.

NCT06892340 — Evaluation of a Device to Reduce Motion Sickness and Spatial Disorientation · NA · recruiting
NCT07126756 — LASIK iDesign vs SMILE · NA · active not recruiting
NCT05844397 — SMILE vs. LASIK Using Contoura With Phorcides · NA · completed
NCT05844384 — Nanodropper Use in Primary Open-Angle Glaucoma Patients: A Non-Inferiority Trial · NA · recruiting
NCT05037370 — CONTOURA vs WFO Ablation PRK & LASIK · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07128316 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by 59th Medical Wing
Last refreshed: 18 August 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07128316.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing